Alzamend Neuro starts Phase 2 trial of AL001 with novel coil tech to test improved lithium delivery in the brain for multiple ...

Jan. 27, 2025 — A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between mania and depression, according to new research.

QMENTA's AI platform will streamline imaging analysis and ensure regulatory compliance during all trials. Alzamend to launch five Phase 2 trials of AL001, including PTSD and bipolar disorder ...

In a groundbreaking study in Biological Psychiatry, published by Elsevier, researchers report significant strides in enhancing early diagnosis of bipolar disorder in adolescents. They demonstrate ...

The imaging findings revealed decreases in excitatory neurotransmitters, which are normally increased in bipolar disorder.